Navigation Links
Revolutionary Pill Promises Relief for Hay Fever Sufferers

For a million of red- nosed, bleary- eyed Britons, relief from hay fever may soon be a pill away. The release of Grazax, a vaccine pill, designed to prevent// allergic reactions like a running nose, itching eyes, sneezing etc. is promised next month.

The vaccine pill contains small amounts of Timothy grass pollen; main allergens in hay fever, and are to be taken daily, eight weeks before hay fever season.

This pill follows the hay fever vaccine injection. This too contains protein derivatives of pollen allergens and is based on immunotherapy too. It promises a respite of 3 years from hay fever after being taken. The drawbacks of the injection vaccine could be serious side effects in one out of 500 cases in addition to the disinclination of many to take monthly jabs. In contrast the pill reports minor side effects like localized swelling under the tongue, where it is placed or mild itching in some persons. The fact that monthly injections can be replaced with popping a pill surely scores for the new vaccine pill.

Grazax manufactured by Danish company ALK-Albello has been granted approval for sale in 27 countries including UK. Costs of treatment though run high. Hundreds of thousands of pounds an year will be incurred by the national health services when the pill is released for prescription.

Trials conducted in hundreds of miserable hay fever suffers have given dramatic results, bettering even usual treatments of anti-histamines and steroid nasal sprays.

As says Professor Stephen Durham, of Imperial College London, who is investigating the long-term benefits of the drug, “One in four people suffers from hay fever. It can have a severe effect on quality of life; it interferes with sleep, and interferes with work, and children with hay fever can drop a grade at school. I believe about 10 per cent of the hay fever population, potentially a million patients in the UK could benefit from this tre
'"/>




Page: 1 2

Related medicine news :

1. Revolutionary Simple Pregnancy Blood Test Can Save Both Mother And Child
2. Revolutionary Pill Cuts Risk of Breast Cancer
3. A Revolutionary New Treatment For Cancer Available In Australia
4. New Revolutionary Drug Could Stop the Spread of HIV
5. Revolutionary New Treatment Plan Developed For Treatment Of Unexplained Symptoms
6. Revolutionary Net To Control Malaria
7. Revolutionary Net To Control Malaria
8. Revolutionary Eye Cancer Treatment
9. Marijuana-Derived Drug Promises Hope In Treating Bladder Infection
10. LINK Applied Genomics Programme Promises To Revolutionize Healthcare Systems
11. Diarrhea Vaccine Trials Promises Prevention of Rotavirus Infection
Post Your Comments:
(Date:7/18/2008)...d Mexican Cuisine are Featured at East LA Meets Na... Services Corporation, LOS ANGELES, July 18 /PRNe...d annual East LA Meets Napa celebration featuring ... wine makers and 20 Los Angeles area Mexican,resta...wine and culinary,enthusiasts who enjoyed great mu...
(Date:7/18/2008)...on the wagon an antidepressant restored brain,s ab... 18 (HealthDay News) -- Giving up your few drinks ...ion, a new study says. , "Our research in an an...nence from alcohol drinking and depression," study...hiatry and pharmacology in the University of North...
(Date:7/18/2008)...t weight loss yields significant health benefits, ...lition -- a group of,experts on overweight and obe...a to reevaluate the way they report on weight loss... news coverage and editorial content that,leads co...ieters if they,lose an enormous amount of weight, ...
(Date:7/18/2008)...Is Not What America Signed Up For, WASHINGTON, Ju...cCain,s,top economic advisor, Phil Gramm, echoed M...were "psychological" by saying Americans are in a ...nation of whiners." While McCain,distanced himself...d as,McCain,s top economic adviser. Now, John McCa...
Breaking Medicine News(10 mins):Health News:Move Over Margarita! Mexican Food has a New Dinner Partner 2Health News:Move Over Margarita! Mexican Food has a New Dinner Partner 3Health News:Research Finds Causal Link Between Ending Drinking, Depression 2Health News:Medical Experts Call on Media to Rethink Coverage of Weight Loss 2Health News:Medical Experts Call on Media to Rethink Coverage of Weight Loss 3Health News:DNC: McCain Watch: The Economy 2Health News:DNC: McCain Watch: The Economy 3
...us University Hospital, Denmark, in a first of its...with a group of ankle injury patients. They found ... in the neck, head, shoulder, arm and even lower b...y of the two groups, pain in the ankle injury grou...
... toenails is a problem that occurs in 1 in 2 perso...y a long standing fungal infection and it gives to...tors at the Mayo Clinic advice consulting with a c...ug. However, these drugs might cause some side eff...
...s Chairman, Tajendra Khanna, in a recent seminar o...ity on 'Managing Corporate Reputation', spoke abou...rugs market. He said that their products would cre...market - Dabur, which has 60 per cent market share...
...r ectopy, another name for premature heart beat, d...searchers to be a better predictor of an increased.... Doctors from Cleveland Clinic Foundation observe...re, valve disease or arrhythmia. They were referre...
Other Medicine News:
(Date:7/16/2008)...orts Pivotal Phase 2b Clinical Trials of First, ...f Cystic Fibrosis -, SOUTH PLAINFIELD, N.J. and B...tics, Inc. (PTC) and Cystic Fibrosis Foundation Th...f the Cystic Fibrosis Foundation, today,announced ...ort development,of PTC124, the PTC,s new investiga...
(Date:7/16/2008)...ly 16 /- MAP,Pharmaceutical...ve results,from a Phase 2 study evaluating the saf...in adult asthmatics were published in the July,iss...armaceuticals is,developing MAP0004, an orally inh... treatment for migraine., The study results, whic...
(Date:7/15/2008)...ewswire/ -- Abeome Corporation, a,Georgia-based bi...investment by Cato BioVentures and a collaboration...arch and development organization. The investment,...lopment of Abeome,s lead,ovarian cancer project., ...he development of,monoclonal antibodies and Abeome...
(Date:7/15/2008)...of Phase III Trials of Light Infusion Therapy,in H...Cancer and Phase I/II and Phase IIa Beni..., July 15 /- Light Sciences Oncology,...ight Infusion Therapy(TM),(Litx(TM)) to treat canc...as raised $40.1 million in a Series C round of fin...
Breaking Medicine Technology:PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124 2PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124 3PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124 4MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 2MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 3MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 4Abeome and Cato Research to Collaborate on Ovarian Cancer Therapeutic 2Light Sciences Oncology Raises $40.1 Million in Series C Financing 2WuXi PharmaTech Completes Acquisition of AppTec 2919 1WuXi PharmaTech Completes Acquisition of AppTec 2919 2Survey 3A Massachusetts Employers Employees Paying Most for Health Care Plans 10689 1Survey 3A Massachusetts Employers Employees Paying Most for Health Care Plans 10689 2Survey 3A Massachusetts Employers Employees Paying Most for Health Care Plans 10689 3DURECT Corporation Invites You to Join Its Fourth Quarter 2007 Earnings Conference Call 2917 1MITs McGovern Institute researchers awarded 248 5M to study brain basis of autism and dyslexia 10682 1MITs McGovern Institute researchers awarded 248 5M to study brain basis of autism and dyslexia 10682 2
...ENCE, Italy - 8 March 2007 - Cancer drug,developer...unces,positive initial findings from its second, c...cell lung cancer. , This 30-patient trial tested a...rboplatin and paclitaxel chemotherapy.,Investigato...of,patients showed disease stabilisation, while on...
...evelopment program of first-in-class CB1,antagonis...ion and,avoid image as life-style drug , BARCELONA...ce,firm La Merie S.L. reported today that Sanofi-A...ia (rimonabant) has at least,five competitors in c...rlier phases of R&D. While Acomplia received E...
Other Medicine Technology:Antisoma plc (UK) - Second lung cancer trial adds to positive data,on AS1404 2Antisoma plc (UK) - Second lung cancer trial adds to positive data,on AS1404 3Weight Management is Not Enough for Cannabinoid Type 1 (CB1),Receptor Antagonists to Become a Commercial Success 2Weight Management is Not Enough for Cannabinoid Type 1 (CB1),Receptor Antagonists to Become a Commercial Success 3
A variety of surgical drapes that provide a vertical barrier to keep the C-arm isolated from the sterile surgical field during hip/femur fracture or trauma procedures. Available with pouches and with
...ll-in-one procedure drape made of 3M™ Steri-...elastic aperture, to create a sterile field during...ake draping quick and convenient by eliminating th...remity drapes with elastic apertures suitable for ...
...OCT, which includes bed side and near patient test...osed unique problems for hospitals and clinical la...sibility to decentralized areas focused on patient... the problem is the reality of controlling staffin...
The Abbott Commander is an automated, high-throughput immunoassay testing system. The Commander System consists of the Flexible Pipetting Center, the Parallel Processing Center, and the Dynamic Incub
Medicine Products: